Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis
Although the pan-genotypic direct-acting antiviral regimen was approved for treating chronic hepatitis C infection regardless of the hepatitis C virus (HCV) genotype, real-world data on its effectiveness against mixed-genotype or genotype-undetermined HCV infection are scarce. We evaluated the real-...
Main Authors: | Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/7/1853 |
Similar Items
-
Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients
by: Hsu-Heng Yen, et al.
Published: (2021-03-01) -
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures
by: Stephanie Popping, et al.
Published: (2021-12-01) -
Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naÏve Patients Infected with Genotype 1b Hepatitis C Virus
by: Ye Wang, et al.
Published: (2015-01-01) -
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019Research in context
by: Daniela K. van Santen, et al.
Published: (2023-02-01) -
Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure
by: João Paulo Vilela Rodrigues, et al.
Published: (2022-11-01)